26 Feb, 2024 09:50 AM
Careteq Limited (ASX: CTQ, “Careteq” or the “Company”), a leader in providing cloud-based assistive living technology solutions and medication management and adherence servic...read more
30 Jan, 2024 09:57 AM
-- Arovella has entered into a global, exclusive license with University of North CarolinaLineberger Comprehensive Cancer Center to incorporate a novel armouring cytokinetechnology (IL-12-TM) for it...read more
30 Jan, 2024 09:13 AM
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a leading innovator in remote monitoring and healthcare technology, is pleased to provide the following quarterly upd...read more
20 Nov, 2023 01:12 PM
Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform, is pleased to announce that it has received its FY202...read more
31 Oct, 2023 10:45 AM
Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a leading innovator in remote monitoring and healthcare technology, is pleased to provide the following quarterl...read more
27 Oct, 2023 12:42 PM
MELBOURNE, AUSTRALIA 27 October 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treat...read more
12 Oct, 2023 09:29 AM
Arovella has entered into a global, exclusive license with Sparx Group to develop a world-first iNKT cell therapy targeting a validated target, Claudin 18.2 (CLDN18.2), which is...read more